DBV Technologies SA (DBVT)
0.4881
-0.02
(-3.92%)
USD |
NASDAQ |
Nov 21, 16:00
0.4801
-0.01
(-1.64%)
After-Hours: 20:00
DBV Technologies Max Drawdown (5Y): 97.67% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 97.67% |
September 30, 2024 | 97.67% |
August 31, 2024 | 97.67% |
July 31, 2024 | 97.67% |
June 30, 2024 | 97.67% |
May 31, 2024 | 97.67% |
April 30, 2024 | 97.67% |
March 31, 2024 | 97.67% |
February 29, 2024 | 97.67% |
January 31, 2024 | 97.67% |
December 31, 2023 | 97.67% |
November 30, 2023 | 97.67% |
October 31, 2023 | 97.67% |
September 30, 2023 | 97.67% |
August 31, 2023 | 97.67% |
July 31, 2023 | 97.67% |
June 30, 2023 | 97.67% |
May 31, 2023 | 97.67% |
April 30, 2023 | 97.67% |
March 31, 2023 | 97.67% |
February 28, 2023 | 97.67% |
January 31, 2023 | 97.67% |
December 31, 2022 | 97.67% |
November 30, 2022 | 97.67% |
October 31, 2022 | 97.67% |
Date | Value |
---|---|
September 30, 2022 | 97.67% |
August 31, 2022 | 97.67% |
July 31, 2022 | 97.67% |
June 30, 2022 | 97.67% |
May 31, 2022 | 97.67% |
April 30, 2022 | 97.53% |
March 31, 2022 | 97.53% |
February 28, 2022 | 97.37% |
January 31, 2022 | 97.20% |
December 31, 2021 | 97.20% |
November 30, 2021 | 97.20% |
October 31, 2021 | 97.20% |
September 30, 2021 | 97.20% |
August 31, 2021 | 97.20% |
July 31, 2021 | 97.20% |
June 30, 2021 | 97.20% |
May 31, 2021 | 97.20% |
April 30, 2021 | 97.20% |
March 31, 2021 | 97.20% |
February 28, 2021 | 97.20% |
January 31, 2021 | 97.20% |
December 31, 2020 | 97.20% |
November 30, 2020 | 97.20% |
October 31, 2020 | 97.20% |
September 30, 2020 | 96.80% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.35%
Minimum
Nov 2019
97.67%
Maximum
May 2022
96.67%
Average
97.60%
Median
Max Drawdown (5Y) Benchmarks
Edap TMS SA | 80.70% |
Cellectis SA | 97.08% |
Genfit SA | -- |
Adaptimmune Therapeutics PLC | 96.57% |
Akari Therapeutics PLC | 98.63% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -54.99 |
Beta (5Y) | 0.6584 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 93.12% |
Historical Sharpe Ratio (5Y) | -0.4993 |
Historical Sortino (5Y) | -1.032 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.16% |